SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

SAMRAT PHARMACHEM

BSE: 530125 19 Aug 2025
Healthcare
₹ 320.5
Samrat Pharmachem Ltd. specializes in Pharmaceuticals within the Healthcare sector.

SAMRAT PHARMACHEM - Share Price & Details

Market Cap
₹99.0
High /Low
646.0 / 302.0
Stock P/E
20.6
Book Value
₹232.0
Dividend Yield
0.31
ROCE
13.6
ROE
₹10.4
Face Value
10.0
PEG Ratio
-0.81
EVEBITDA
₹12.2
Debt
9.91
CMP / FCF
-23.6
Debt to equity
₹0.14
NP Ann
7.11
High price all time
1,250
Piotroski score
₹6.0
Graham Number
285.0
No. Eq. Shares
0.31
Net CF
₹-9.62
Net profit
4.81
Price to book value
1.38
Interest Coverage
₹8.83
Low price all time
6.21
Industry PE
33.8
Reserves
₹68.7
Free Cash Flow
₹-10.6

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
SAMRAT PHARMACHEM LTD.710.96-3.99712.03-1.2999.020.6
IND-SWIFT LTD.1535.542565.991449.0447.3794.51.47
SOURCE NATURAL FOODS & HERBAL161.246.27160.650.9788.828.5

Peer Comparison Chart


About SAMRAT PHARMACHEM

Samrat Pharmachem Ltd., with Security Code 530125, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Samrat Pharmachem Reports Declining Profitability in August 2025 Financial Results

(15 Aug 2025)
Samrat Pharmachem has announced its financial results for the quarter ending June 2025, revealing challenges in profitability.
Read more →

What are the latest earnings results for RF Industries Ltd. - Invest smarter with data-backed trading alerts

(04 Aug 2025)
【Investment News】✌️ Experience the power of high-precision forecasting — with many of our top picks hitting 200%+ returns.
Read more →

Colgate (COLPAL) Hits 52 Week High - Discover breakthrough investment opportunities

(04 Aug 2025)
【Market Focus】✌️ Why settle for average returns when you can earn over 200% with our expert insights and real-time analytics?
Read more →

Samrat Pharmachem Limited (530125) Gets Regulatory Approval - Free Capital Efficiency Planning

(03 Aug 2025)
Samrat Pharmachem Limited (530125) Gets Regulatory Approval ✌️【Stock Trends】✌️ Get instant access to expert-curated watchlists and market...
Read more →

What are analysts’ price targets for Horizon Funds Expedition Plus Etf in the next 12 months - Achieve breakthrough profits with expert advice

(28 Jul 2025)
【Stock Observations】✌️ Don't settle for single-digit annual gains — our platform helps you pinpoint fast-moving stocks before they trend...
Read more →

Is DigiAsia Corp. a good long term investment - Extraordinary performance

(26 Jul 2025)
【Market Watch】✌️ From tech innovators to emerging market leaders, we track high-velocity stocks that consistently produce 200%+ returns,...
Read more →

Company Updates